These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9315597)

  • 1. Pravastatin alone and in combination with low-dose cholestyramine in patients with primary hypercholesterolemia and coronary artery disease.
    Ito MK; Shabetai R
    Am J Cardiol; 1997 Sep; 80(6):799-802. PubMed ID: 9315597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P
    Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
    Ditschuneit HH; Dreyer M; Dammann HG; Ditschuneit H
    Med Klin (Munich); 1991 Mar; 86(3):142-8. PubMed ID: 1903497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.
    Eriksson M; Hådell K; Holme I; Walldius G; Kjellström T
    J Intern Med; 1998 May; 243(5):373-80. PubMed ID: 9651560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemia.
    Jacob BG; Richter WO; Schwandt P
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):396-400. PubMed ID: 7504129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia.
    Pan HY; DeVault AR; Swites BJ; Whigan D; Ivashkiv E; Willard DA; Brescia D
    Clin Pharmacol Ther; 1990 Aug; 48(2):201-7. PubMed ID: 2116260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
    Arntz HR; Agrawal R; Wunderlich W; Schnitzer L; Stern R; Fischer F; Schultheiss HP
    Am J Cardiol; 2000 Dec; 86(12):1293-8. PubMed ID: 11113401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
    Bard JM; Ose L; Hagen E; Duriez P; Pfister P; Fruchart JC; Dallongeville J
    Am J Cardiol; 1995 Jul; 76(2):65A-70A. PubMed ID: 7604802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of coronary heart disease with pravastatin.
    Rogers S
    N Engl J Med; 1996 May; 334(20):1333; author reply 1334-5. PubMed ID: 8609956
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database.
    Peters TK
    Am J Cardiol; 1995 Jul; 76(2):71A-75A. PubMed ID: 7604803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia.
    Kajinami K; Yagi K; Higashikata T; Inazu A; Koizumi J; Mabuchi H
    Am J Cardiol; 1998 Jul; 82(1):113-7. PubMed ID: 9671018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
    Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study].
    Arntz HR; Wunderlich W; Schnitzer L; Stern R; Fischer F; Agrawal R; Linderer T; Schultheiss HP
    Z Kardiol; 1999 Aug; 88(8):582-90. PubMed ID: 10506395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan.
    Nagata-Kobayashi S; Shimbo T; Matsui K; Fukui T
    Int J Cardiol; 2005 Sep; 104(2):213-23. PubMed ID: 16168816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.
    Sprecher DL; Abrams J; Allen JW; Keane WF; Chrysant SG; Ginsberg H; Fischer JJ; Johnson BF; Theroux P; Jokubaitis L
    Ann Intern Med; 1994 Apr; 120(7):537-43. PubMed ID: 8093139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin].
    Pokrovskaia EV; Vaulin NA; Gratsianskiĭ NA; Averkov OV; Deev AD
    Kardiologiia; 2003; 43(1):7-18. PubMed ID: 12891281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over study.
    Kietsiriroje N; Leelawattana R
    BMC Res Notes; 2015 Jul; 8():294. PubMed ID: 26148680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More on pravastatin and coronary disease.
    Grundy SM
    N Engl J Med; 1996 Oct; 335(16):1239-40. PubMed ID: 8999328
    [No Abstract]   [Full Text] [Related]  

  • 20. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
    Morris R; Robinson G; Tilyard M; Gurr E
    N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.